XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
about
Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression.A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinoma.Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair.
P2860
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
@ast
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
@en
type
label
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
@ast
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
@en
prefLabel
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
@ast
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
@en
P2860
P1433
P1476
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
@en
P2093
Sitian Yang
Xiao Qi Wang
P2860
P2888
P356
10.1186/S12885-017-3345-Y
P407
P577
2017-05-19T00:00:00Z
P6179
1085437672